Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T13:36:27.409Z.
Calculation as of: 2026-10-06T13:36:27.409Z.
Quote observation: 2026-10-06T13:34:54.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: d443e069440aa0ac5a32f25afa0d38c48efe58a411ec60778b8439bb1c5cf92a
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
Eledon Pharmaceuticals, Inc.
Market Cap
$194.51M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$184.12M
EV/FCF Ratio
N/A
TTM Avg
72.04x
3Y Avg
55.57x
5Y Avg
55.57x
Market Cap
$180.08M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$175.27M
EV/FCF Ratio
N/A
TTM Avg
277.79x
3Y Avg
277.79x
5Y Avg
277.79x
Market Cap
$172.27M
EV/FCF Ratio
N/A
TTM Avg
568.17x
3Y Avg
568.17x
5Y Avg
88.75x
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | $194.51M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $198.09M | N/A | N/A | N/A | N/A |
| Electra Therapeutics Inc. (ETRA)vs › | $202.16M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $184.12M | N/A | 72.04x | 55.57x | 55.57x |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.08M | N/A | N/A | N/A | N/A |
| Compass Therapeutics, Inc. (CMPX)vs › | $171.10M | N/A | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $175.27M | N/A | 277.79x | 277.79x | 277.79x |
| Cue Biopharma, Inc. (CUE)vs › | $177.91M | N/A | N/A | N/A | N/A |
| Coherus Oncology, Inc. (CHRS)vs › | $172.27M | N/A | 568.17x | 568.17x | 88.75x |
| Compugen Ltd. (CGEN)vs › | $219.84M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
